{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:18:48Z","timestamp":1781756328849,"version":"3.54.5"},"reference-count":65,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,23]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Inflammatory stimuli have divergent effects on peripheral platelet counts, although the mechanisms of thrombocytopenic and thrombocytotic responses remain poorly understood. A candidate gene approach targeting 326 polymorphic genes enriched in thrombopoietic and cytokine signaling pathways was applied to identify single nucleotide variants (SNVs) implicated in enhanced platelet responses in cohorts with reactive thrombocytosis (RT) or essential (myeloproliferative neoplasm [MPN]) thrombocytosis (ET). Cytokine profiles incorporating a 15-member subset, pathway topology, and functional interactive networks were distinct between ET and RT, consistent with distinct regulatory pathways of exaggerated thrombopoiesis. Genetic studies using aggregate (ET + RT) or ET-restricted cohorts identified associations with 2 IFNA16 (interferon-\u03b116) SNVs, and the ET associations were validated in a second independent cohort (P = .0002). Odds ratio of the combined ET cohort (n = 105) was 4.92, restricted to the JAK2V617F-negative subset (odds ratio, 5.01). ET substratification analysis by variant IFNA16 exhibited a statistically significant increase in IFN-\u03b116 levels (P = .002) among 16 quantifiable cytokines. Recombinantly expressed variant IFN-\u03b116 encompassing 3 linked non-synonymous SNVs (E65H95P133) retained comparable antiviral and pSTAT signaling profiles as native IFN-\u03b116 (V65D95A133) or IFN-\u03b12, although both native and variant IFN-\u03b116 showed stage-restricted differences (compared with IFN-\u03b12) of IFN-regulated genes in CD34+-stimulated megakaryocytes. These data implicate IFNA16 (IFN-\u03b116 gene product) as a putative susceptibility locus (driver) within the broader disrupted cytokine network evident in MPNs, and they provide a framework for dissecting functional interactive networks regulating stress or MPN thrombopoiesis.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021005648","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T19:59:51Z","timestamp":1649188791000},"page":"4884-4900","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["Cytokine pathway variants modulate platelet production:<i>IFNA16<\/i>is a thrombocytosis susceptibility locus in humans"],"prefix":"10.1182","volume":"6","author":[{"given":"Dmitri V.","family":"Gnatenko","sequence":"first","affiliation":[{"name":"1Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0847-2286","authenticated-orcid":false,"given":"Zhaoyan","family":"Liu","sequence":"additional","affiliation":[{"name":"2Department of Applied Mathematics and Statistics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Hearing","sequence":"additional","affiliation":[{"name":"3Department of Microbiology and Immunology, State University of New York at Stony Brook, Stony Brook, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sook-Young","family":"Sohn","sequence":"additional","affiliation":[{"name":"3Department of Microbiology and Immunology, State University of New York at Stony Brook, Stony Brook, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yetao","family":"Hu","sequence":"additional","affiliation":[{"name":"2Department of Applied Mathematics and Statistics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0338-2000","authenticated-orcid":false,"given":"Anna","family":"Falanga","sequence":"additional","affiliation":[{"name":"4Department of Medicine and Surgery, University of Milan Bicocca, Milan, Italy; and"},{"name":"5Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Wu","sequence":"additional","affiliation":[{"name":"2Department of Applied Mathematics and Statistics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa E.","family":"Malone","sequence":"additional","affiliation":[{"name":"1Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3218-8573","authenticated-orcid":false,"given":"Wei","family":"Zhu","sequence":"additional","affiliation":[{"name":"2Department of Applied Mathematics and Statistics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wadie F.","family":"Bahou","sequence":"additional","affiliation":[{"name":"1Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"2022082518323511800_B1","first-page":"221","volume-title":"Genomics and Clinical Medicine.","author":"Bahou","year":"2006"},{"issue":"5","key":"2022082518323511800_B2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MOH.0b013e32832e9dc6","article-title":"The platelet proteome","volume":"16","author":"Senzel","year":"2009","journal-title":"Curr Opin Hematol."},{"issue":"18","key":"2022082518323511800_B3","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood-2013-11-462432","article-title":"Emerging roles for platelets as immune and inflammatory cells","volume":"123","author":"Morrell","year":"2014","journal-title":"Blood."},{"issue":"4","key":"2022082518323511800_B4","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.stem.2015.07.007","article-title":"Inflammation-induced emergency megakaryopoiesis driven by hematopoietic stem cell-like megakaryocyte progenitors","volume":"17","author":"Haas","year":"2015","journal-title":"Cell Stem Cell."},{"issue":"9","key":"2022082518323511800_B5","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1182\/blood.V98.9.2720","article-title":"Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis","volume":"98","author":"Kaser","year":"2001","journal-title":"Blood."},{"issue":"4","key":"2022082518323511800_B6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0022-2143(99)90154-3","article-title":"Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosis","volume":"134","author":"Hsu","year":"1999","journal-title":"J Lab Clin Med."},{"issue":"5","key":"2022082518323511800_B7","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/leu.2016.12","article-title":"Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both","volume":"30","author":"Koschmieder","year":"2016","journal-title":"Leukemia."},{"key":"2022082518323511800_B8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaut.2017.06.010","article-title":"Inflammation and myeloproliferative neoplasms","volume":"85","author":"Lussana","year":"2017","journal-title":"J Autoimmun."},{"issue":"17","key":"2022082518323511800_B9","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1182\/blood-2012-02-411264","article-title":"Systematic analysis of microRNA fingerprints in thrombocythemic platelets using integrated platforms","volume":"120","author":"Xu","year":"2012","journal-title":"Blood."},{"issue":"4","key":"2022082518323511800_B10","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/ng.341","article-title":"A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms","volume":"41","author":"Olcaydu","year":"2009","journal-title":"Nat Genet."},{"issue":"4","key":"2022082518323511800_B11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ng.342","article-title":"A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms","volume":"41","author":"Kilpivaara","year":"2009","journal-title":"Nat Genet."},{"issue":"4","key":"2022082518323511800_B12","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/ng.334","article-title":"JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms","volume":"41","author":"Jones","year":"2009","journal-title":"Nat Genet."},{"issue":"8","key":"2022082518323511800_B13","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ng.175","article-title":"Genome-wide association defines more than 30 distinct susceptibility loci for Crohn\u2019s disease","volume":"40","author":"Barrett","year":"2008","journal-title":"Nat Genet."},{"issue":"1","key":"2022082518323511800_B14","first-page":"77","article-title":"Long-term intra-individual variation of platelet parameters","volume":"46","author":"Siebers","year":"1989","journal-title":"Med Lab Sci."},{"issue":"1","key":"2022082518323511800_B15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1182\/blood.V95.1.342","article-title":"Genetic influences on F cells and other hematologic variables: a twin heritability study","volume":"95","author":"Garner","year":"2000","journal-title":"Blood."},{"issue":"2","key":"2022082518323511800_B16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/gepi.1370020204","article-title":"Genetic and environmental influences on the size and number of cells in the blood","volume":"2","author":"Whitfield","year":"1985","journal-title":"Genet Epidemiol."},{"issue":"1","key":"2022082518323511800_B17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ajh.20095","article-title":"Association of single nucleotide polymorphisms in the thrombopoietin-receptor gene, but not the thrombopoietin gene, with differences in platelet count","volume":"77","author":"Zeng","year":"2004","journal-title":"Am J Hematol."},{"issue":"7376","key":"2022082518323511800_B18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature10659","article-title":"New gene functions in megakaryopoiesis and platelet formation","volume":"480","author":"Gieger","year":"2011","journal-title":"Nature."},{"issue":"7429","key":"2022082518323511800_B19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nature11677","article-title":"Seventy-five genetic loci influencing the human red blood cell","volume":"492","author":"van der Harst","year":"2012","journal-title":"Nature."},{"issue":"5","key":"2022082518323511800_B20","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.cell.2016.10.042","article-title":"The allelic landscape of human blood cell trait variation and links to common complex disease","volume":"167","author":"Astle","year":"2016","journal-title":"Cell."},{"issue":"47","key":"2022082518323511800_B21","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1038\/sj.onc.1210757","article-title":"Hematopoietic cytokine receptor signaling","volume":"26","author":"Baker","year":"2007","journal-title":"Oncogene."},{"issue":"1","key":"2022082518323511800_B22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2009-05-224477","article-title":"Class prediction models of thrombocytosis using genetic biomarkers","volume":"115","author":"Gnatenko","year":"2010","journal-title":"Blood."},{"issue":"1","key":"2022082518323511800_B23","first-page":"29","article-title":"Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment","volume":"34","author":"Murphy","year":"1997","journal-title":"Semin Hematol."},{"issue":"4","key":"2022082518323511800_B24","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood-2007-04-083501","article-title":"Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel","volume":"110","author":"Tefferi","year":"2007","journal-title":"Blood."},{"issue":"10","key":"2022082518323511800_B25","doi-asserted-by":"crossref","first-page":"e0141010","DOI":"10.1371\/journal.pone.0141010","article-title":"Calreticulin mutations in myeloproliferative neoplasms: comparison of three diagnostic methods","volume":"10","author":"Park","year":"2015","journal-title":"PLoS One."},{"issue":"2","key":"2022082518323511800_B26","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1160\/TH05-01-0037","article-title":"Platelets express steroidogenic 17beta-hydroxysteroid dehydrogenases. Distinct profiles predict the essential thrombocythemic phenotype","volume":"94","author":"Gnatenko","year":"2005","journal-title":"Thromb Haemost."},{"issue":"7","key":"2022082518323511800_B27","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1182\/blood-2009-02-202614","article-title":"A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways","volume":"114","author":"Jones","year":"2009","journal-title":"Blood."},{"issue":"7","key":"2022082518323511800_B28","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/sim.4780090710","article-title":"More powerful procedures for multiple significance testing","volume":"9","author":"Hochberg","year":"1990","journal-title":"Stat Med."},{"issue":"3","key":"2022082518323511800_B29","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1097\/HS9.0000000000000371","article-title":"Longitudinal cytokine profiling identifies GRO-\u03b1 and EGF as potential biomarkers of disease progression in essential thrombocythemia","volume":"4","author":"\u00d8bro","year":"2020","journal-title":"HemaSphere."},{"issue":"3","key":"2022082518323511800_B30","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1160\/TH12-08-0634","article-title":"Molecular circuits in thrombosis and inflammation","volume":"109","author":"Esmon","year":"2013","journal-title":"Thromb Haemost."},{"issue":"5","key":"2022082518323511800_B31","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.exphem.2014.01.006","article-title":"Cytokine profiles in polycythemia vera and essential thrombocythemia patients: clinical implications","volume":"42","author":"Pourcelot","year":"2014","journal-title":"Exp Hematol."},{"key":"2022082518323511800_B32","doi-asserted-by":"crossref","first-page":"389257","DOI":"10.1155\/2014\/389257","article-title":"Clinicohematological study of thrombocytosis in children","volume":"2014","author":"Subramaniam","year":"2014","journal-title":"ISRN Hematol."},{"issue":"6","key":"2022082518323511800_B33","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1182\/blood-2002-09-2797","article-title":"Transcript profiling of human platelets using microarray and serial analysis of gene expression","volume":"101","author":"Gnatenko","year":"2003","journal-title":"Blood."},{"key":"2022082518323511800_B34","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.freeradbiomed.2020.12.015","article-title":"Divergent erythroid megakaryocyte fates in Blvrb-deficient mice establish non-overlapping cytoprotective functions during stress hematopoiesis","volume":"164","author":"Nesbitt","year":"2021","journal-title":"Free Radic Biol Med."},{"issue":"5","key":"2022082518323511800_B35","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1182\/blood-2016-02-696997","article-title":"BLVRB redox mutation defines heme degradation in a metabolic pathway of enhanced thrombopoiesis in humans","volume":"128","author":"Wu","year":"2016","journal-title":"Blood."},{"issue":"1","key":"2022082518323511800_B36","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12859-017-1559-2","article-title":"Reactome pathway analysis: a high-performance in-memory approach","volume":"18","author":"Fabregat","year":"2017","journal-title":"BMC Bioinformatics."},{"issue":"5","key":"2022082518323511800_B37","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/bimj.201300192","article-title":"Global adaptive rank truncated product method for gene-set analysis in association studies","volume":"56","author":"Vilor-Tejedor","year":"2014","journal-title":"Biom J."},{"issue":"8","key":"2022082518323511800_B38","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood-2007-10-119677","article-title":"Point mutation in the gene encoding p300 suppresses thrombocytopenia in Mpl-\/-\u00a0mice","volume":"112","author":"Kauppi","year":"2008","journal-title":"Blood."},{"issue":"1","key":"2022082518323511800_B39","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/imr.12001","article-title":"Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation","volume":"250","author":"Piehler","year":"2012","journal-title":"Immunol Rev."},{"issue":"6","key":"2022082518323511800_B40","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"2022082518323511800_B41","doi-asserted-by":"crossref","first-page":"D1040","DOI":"10.1093\/nar\/gks1215","article-title":"Interferome v2.0: an updated database of annotated interferon-regulated genes","volume":"41","author":"Rusinova","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"2022082518323511800_B42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12575-009-9012-1","article-title":"MicroRNA expression profiling by bead array technology in human tumor cell lines treated with interferon-alpha-2a","volume":"11","author":"Siegrist","year":"2009","journal-title":"Biol Proced Online."},{"issue":"4","key":"2022082518323511800_B43","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cell.2011.06.048","article-title":"Structural linkage between ligand discrimination and receptor activation by type I interferons","volume":"146","author":"Thomas","year":"2011","journal-title":"Cell."},{"issue":"11","key":"2022082518323511800_B44","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nrg2452","article-title":"Epistasis \u2013 the essential role of gene interactions in the structure and evolution of genetic systems","volume":"9","author":"Phillips","year":"2008","journal-title":"Nat Rev Genet."},{"issue":"1","key":"2022082518323511800_B45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cytogfr.2008.11.006","article-title":"Cytokine and cytokine receptor gene polymorphisms and their functionality","volume":"20","author":"Smith","year":"2009","journal-title":"Cytokine Growth Factor Rev."},{"issue":"7","key":"2022082518323511800_B46","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI2629","article-title":"The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis","volume":"102","author":"Fishman","year":"1998","journal-title":"J Clin Invest."},{"issue":"3","key":"2022082518323511800_B47","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/omi.2010.0093","article-title":"IL-6-174G\/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma","volume":"15","author":"Giannitrapani","year":"2011","journal-title":"OMICS."},{"issue":"11","key":"2022082518323511800_B48","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/hmg\/ddl113","article-title":"Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis","volume":"15","author":"Qi","year":"2006","journal-title":"Hum Mol Genet."},{"issue":"24","key":"2022082518323511800_B49","doi-asserted-by":"crossref","first-page":"18138","DOI":"10.1074\/jbc.M000379200","article-title":"Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation","volume":"275","author":"Terry","year":"2000","journal-title":"J Biol Chem."},{"issue":"2","key":"2022082518323511800_B50","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2265.2008.03315.x","article-title":"Interleukin-6 (IL-6) -572C--&gt;G promoter polymorphism is associated with type 2 diabetes risk in Koreans","volume":"70","author":"Koh","year":"2009","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"5","key":"2022082518323511800_B51","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.4049\/jimmunol.165.5.2783","article-title":"Proinflammatory effects of IL-10 during human endotoxemia","volume":"165","author":"Lauw","year":"2000","journal-title":"J Immunol."},{"issue":"2","key":"2022082518323511800_B52","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/gut.50.2.191","article-title":"Treatment of Crohn\u2019s disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma","volume":"50","author":"Tilg","year":"2002","journal-title":"Gut."},{"issue":"1","key":"2022082518323511800_B53","first-page":"104","article-title":"Interleukin 10-induced thrombocytopenia in normal healthy adult volunteers: evidence for decreased platelet production","volume":"111","author":"Sosman","year":"2000","journal-title":"Br J Haematol."},{"issue":"15","key":"2022082518323511800_B54","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1182\/blood-2012-05-433466","article-title":"A3669G polymorphism of glucocorticoid receptor is a susceptibility allele for primary myelofibrosis and contributes to phenotypic diversity and blast transformation","volume":"120","author":"Poletto","year":"2012","journal-title":"Blood."},{"issue":"1","key":"2022082518323511800_B55","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.1038\/ncomms7691","article-title":"Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms","volume":"6","author":"Tapper","year":"2015","journal-title":"Nat Commun."},{"issue":"1","key":"2022082518323511800_B56","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ajh.24946","article-title":"MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: a study on 939 patients","volume":"93","author":"Trifa","year":"2018","journal-title":"Am J Hematol."},{"issue":"7831","key":"2022082518323511800_B57","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41586-020-2786-7","article-title":"Inherited myeloproliferative neoplasm risk affects haematopoietic stem cells","volume":"586","author":"Bao","year":"2020","journal-title":"Nature."},{"issue":"2","key":"2022082518323511800_B58","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1182\/blood-2010-07-296921","article-title":"The dominant negative \u03b2 isoform of the glucocorticoid receptor is uniquely expressed in erythroid cells expanded from polycythemia vera patients","volume":"118","author":"Varricchio","year":"2011","journal-title":"Blood."},{"issue":"10","key":"2022082518323511800_B59","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1038\/s41375-020-0767-3","article-title":"miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk","volume":"34","author":"Ferrer-Mar\u00edn","year":"2020","journal-title":"Leukemia."},{"issue":"10","key":"2022082518323511800_B60","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1038\/s41375-018-0088-y","article-title":"The -2518 A\/G polymorphism of the monocyte chemoattractant protein-1 as a candidate genetic predisposition factor for secondary myelofibrosis and biomarker of disease severity","volume":"32","author":"Masselli","year":"2018","journal-title":"Leukemia."},{"issue":"6","key":"2022082518323511800_B61","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1182\/blood-2012-07-442012","article-title":"Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon \u03b1-2a","volume":"122","author":"Quint\u00e1s-Cardama","year":"2013","journal-title":"Blood."},{"issue":"3","key":"2022082518323511800_B62","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/ph2030206","article-title":"Interferons as therapy for viral and neoplastic diseases: from panacea to pariah to paragon","volume":"2","author":"Friedman","year":"2009","journal-title":"Pharmaceuticals (Basel)."},{"issue":"11","key":"2022082518323511800_B63","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1182\/blood-2010-03-274605","article-title":"Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease","volume":"116","author":"Lood","year":"2010","journal-title":"Blood."},{"issue":"17","key":"2022082518323511800_B64","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1182\/blood-2016-08-736108","article-title":"Slowed decay of mRNAs enhances platelet specific translation","volume":"129","author":"Mills","year":"2017","journal-title":"Blood."},{"issue":"19","key":"2022082518323511800_B65","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/blood-2018-09-873984","article-title":"Human megakaryocytes possess intrinsic antiviral immunity through regulated induction of IFITM3","volume":"133","author":"Campbell","year":"2019","journal-title":"Blood."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/16\/4884\/1917937\/advancesadv2021005648.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/16\/4884\/1917937\/advancesadv2021005648.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T17:44:02Z","timestamp":1700415842000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/16\/4884\/484607\/Cytokine-pathway-variants-modulate-platelet"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":65,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2022,8,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021005648","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]}}}